Evidence map›Paper›PMID 28717237›Full record

ArticleScientific reports2017

Fat binding capacity and modulation of the gut microbiota both determine the effect of wheat bran fractions on adiposity.

Francesco Suriano, Laure B Bindels, Joran Verspreet, Christophe M Courtin, Kristin Verbeke, Patrice D Cani, Audrey M Neyrinck, Nathalie M Delzenne

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Effects of Wheat Bran andAnimals : an open access journal from MDPI · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Francesco SurianoMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200, Brussels, Belgium.
Laure B BindelsMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200, Brussels, Belgium.ORCID 0000-0003-3747-3234
Joran VerspreetLaboratory of Food Chemistry and Biochemistry, Leuven Food Science and Nutrition, Research Center (LFoRCe). KU Leuven, B-3001, Leuven, Belgium.
Christophe M CourtinLaboratory of Food Chemistry and Biochemistry, Leuven Food Science and Nutrition, Research Center (LFoRCe). KU Leuven, B-3001, Leuven, Belgium.ORCID 0000-0002-1203-9063
Kristin VerbekeTranslational Research Center for Gastrointestinal Disorders and Leuven Food Science and Nutrition Center, KU Leuven, B-3000, Leuven, Belgium.
Patrice D CaniMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200, Brussels, Belgium.ORCID 0000-0003-2040-2448
Audrey M NeyrinckMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200, Brussels, Belgium.
Nathalie M DelzenneMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200, Brussels, Belgium. nathalie.delzenne@uclouvain.be.
UCLouvain · BEKU Leuven · BEWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

European Research Council 336452
6 · The paper itself

Abstract

The aim of this study was to determine the impact of different wheat bran fractions on the gut microbiota and fat binding capacity to explain their differential effects on metabolic and inflammatory disorders induced by a western diet (WD) in mice. Wheat bran derived arabinoxylan oligosaccharides (AXOS), a crude fraction of wheat bran (WB), or the same wheat bran with reduced particle size (WBs) were added to the WD of mice for 8 weeks. AXOS shifted the gut microbiota composition, blunted Clostridium and Turicibacter genera and strongly promoted Bifidobacterium and Butyricicoccus genera, independently of changes in gut antimicrobial peptide expression. AXOS was the most efficient to reduce adiposity. Only WB fraction promoted fat excretion and differed from the other fractions by the capacity to increase the Akkermansia genus and to counteract gut interleukin 1 beta (IL1β) overexpression. Strikingly, WBs promoted steatosis and adipose tissue inflammation, despite its ability -like WB- to increase bacterial diversity. In conclusion, wheat bran fractions differently affect metabolic and inflammatory disorders associated with WD feeding, depending on their particle size, their fat binding capacity and their influence on the gut microbiota. Those results might be useful to take into account in nutritional advices to control obesity.

Indexed as

AdiposityAnimalsBacteriaBifidobacteriumClostridiaceaeDietary FiberDiet, WesternDNA, BacterialDNA, RibosomalGastrointestinal MicrobiomeGastrointestinal TractInterleukin-1betaMicePhylogenyRNA, Ribosomal, 16SSequence Analysis, DNAarabinoxylanDietary FiberDNA, BacterialDNA, RibosomalIL1B protein, mouseInterleukin-1betaRNA, Ribosomal, 16SXylans

Identifiers

PMID28717237
PMCPMC5514075
OpenAlexW2734201743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.